Connect with us

Technology

QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be Presented at EASD Annual Meeting 2024

Published

on

– Abstract on data from a two-part phase 1c, multiple ascending dose study accepted for oral presentation –

– New data highlighting the Company’s lead drug candidate ZT002 for obesity –

BEIJING, Sept. 3, 2024 /PRNewswire/ — Beijing QL Biopharmaceutical Co., Ltd. (“QL Biopharm”), a clinical stage biopharmaceutical company developing innovative biologic drugs for the treatment of metabolic diseases, today announces that an abstract on its lead drug candidate ZT002 will be presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024, Madrid, Spain on Thursday 12 September 2024.

QL Biopharm’s lead asset, ZT002 is a novel ultra long-acting glucagon-like peptide-1 receptor agonist (“GLP-1 RA”) in development for obesity with monthly subcutaneous administration. The phase 1c, randomized, placebo-controlled, double-blind multiple ascending dose study was conducted in 28 patients with obesity. Patients were randomly assigned to receive either ZT002 or placebo. Results from the study showed that ZT002 had a favorable safety and tolerability profile. Further, ZT002 induced clinically meaningful weight loss with associated cardiometabolic improvements.

Dr. Zhang Xujia, Ph.D., Founder, Chairman and Chief Executive Officer of QL Biopharm said: “The emerging profile of ZT002 holds great promise as a new standard of care for patients living with obesity. The safety and tolerability seen in patients receiving ZT002 is aligned with the GLP-1RA class. ZT002 has the potential to simplify obesity treatment. We look forward to advancing our ongoing studies and further exploring the potential of ZT002 for weight management and type 2 diabetes treatment.”

Details of the EASD Annual Meeting 2024 poster presentation are as follows:

Title: ZT002, a novel ultra long-acting glp-1 receptor agonist in adults with overweight or obesity: a randomized, placebo-controlled, multiple ascending dose phase 1c study

Session: OP 25 Incretin receptor agonists: better and better

Date and Time: Thursday, 12 September 2024, 11:15 – 11:30 CEST

Presenter: Linong Ji, MD, Professor of Medicine at Peking University People’s Hospital

Location: Madrid Hall

Abstract Number: 147

For more information about the EASD Annual Meeting 2024, including details related to accepted abstracts and presentations, please visit its website. The Abstract is available on the EASD online planner here.

NOTES TO EDITORS

About QL Biopharm

QL Biopharm is a clinical-stage biopharmaceutical company focused on developing novel best-in-class peptide therapeutics for metabolic diseases. The Company leverages its proprietary E. coli manufacturing process enabling rapid and cost-effective scaling of manufacturing for high volume markets. The lead drug candidate, ZT002, is an ultra long-acting subcutaneously administered GLP-1 receptor agonist, currently in a Phase 2 study for obesity and in Phase 1 for type 2 diabetes. In Phase 1 studies, ZT002 demonstrated compelling weight loss and tolerability consistent with the GLP-1 RA class. The Company is also advancing a broader portfolio of novel preclinical assets for the treatment of metabolic diseases, in addition to its biosimilar semaglutide program, currently in Phase 3. QL Biopharm is led by a team of pharma industry veterans with expertise in E. coli–based peptide manufacturing and the development of drugs for metabolic diseases. The Company is backed by leading professional life science investors.

For additional information, please visit https://qlbiopharm.com/

About EASD

The European Association for the Study of Diabetes e.V. (EASD) is a membership-based academic non-profit organization. It was founded in 1965 and its headquarters is based in Duesseldorf, Germany. The aims of the Association are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge and to facilitate its application.

View original content:https://www.prnewswire.co.uk/news-releases/ql-biopharm-announces-abstract-on-novel-ultra-long-acting-glp-1ra-to-be-presented-at-easd-annual-meeting-2024-302236190.html

Continue Reading

Technology

SpeedBuilder Systems Celebrates 25 Years of Building Technology and Lasting Relationships in the P&C Insurance Industry

Published

on

By

From its beginnings with a rating solution to an integrated insurance platform, SpeedBuilder Systems marks a quarter-century of helping insurers adapt, innovate, and grow.

COLUMBIA, S.C., Oct. 20, 2026 /PRNewswire/ — SpeedBuilder Systems, Inc. (SBS), an award-winning provider of software-as-a-service (SaaS) solutions for the property and casualty (P&C) insurance industry, is celebrating its 25th anniversary, marking a quarter-century of delivering flexible insurance technology and building long-term relationships with its clients.

Founded on October 10, 2001, by Rod Giess, president of SpeedBuilder Systems, the company began with a vision and a rating solution designed to help insurers bring products to market more efficiently.

“When I started SpeedBuilder Systems, my goal wasn’t to be the biggest. It was simply to be the best at delivering quality technology that would help our clients get to market as quickly as possible,” said Giess. “I believed then, as I do today, that innovative insurance companies deserve access to sophisticated technology, regardless of their size.”

As the business developed, Giess recognized the need for a policy administration system to complement the company’s rating solution. What began as two complementary capabilities has grown into the BindExpress Suite, an integrated insurance platform supporting policy administration, rating, underwriting, billing, claims, and other core insurance operations. Designed for small to medium-sized property and casualty insurers and managing general agents (MGAs), the platform provides the flexibility to accommodate unique business requirements while supporting growth and changing market demands.

Throughout its history, SBS has maintained a consistent philosophy: technology should support an insurer’s business objectives rather than dictate how the organization operates. That approach is reflected in the company’s commitment to configurable software, long-term technology planning, and close collaboration with its clients.

“I’m very proud of how far this company has come, but what means the most to me are the relationships we’ve built along the way,” Giess continued. “Our clients have trusted us with an important part of their businesses, and we’ve never taken that responsibility lightly. I’m grateful to our clients for their continued partnership and to our team, past and present, whose dedication and hard work have brought us to this milestone.”

As SpeedBuilder Systems looks ahead, the company remains committed to helping insurers adapt to an evolving industry while maintaining greater control over their technology and business operations. The company will continue investing in its technology, strengthening client relationships, and supporting insurers as they pursue new opportunities.

About SpeedBuilder Systems

Founded in 2001, SpeedBuilder Systems, Inc. provides enterprise-class insurance software solutions for small and medium-sized property and casualty insurers and MGAs. Its BindExpress Suite® is an integrated set of components including policy administration, rating, automated underwriting, agent and consumer portals, product configuration, billing, claims, automated workflow, and document generation. The company’s AlwaysCurrent Architecture™ enables customers to tailor the system to their unique requirements while adopting future product enhancements without costly retrofitting of customized code.

For more information, visit www.speedbuildersystems.com.

Media Contact
Amy Gillespie
SpeedBuilder Systems, Inc.
agillespie@speedbuildersystems.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/speedbuilder-systems-celebrates-25-years-of-building-technology-and-lasting-relationships-in-the-pc-insurance-industry-302912235.html

SOURCE SpeedBuilder Systems, Inc.

Continue Reading

Technology

Ally Financial reports third quarter 2026 financial results

Published

on

By

CHARLOTTE, N.C., Oct. 20, 2026 /PRNewswire/ — Ally Financial (NYSE: ALLY) today reported its third quarter 2026 results. View full press release in PDF.

The news release, presentation and financial supplement can be accessed in the following ways:

Ally Financial Press Room at https://media.ally.comAlly Financial Investor Relations website at https://ally.com/about/investor/

Ally will host a conference call at 9 a.m. ET to review the company’s performance. The call will include a review of the results, followed by a question and answer session.

Conference Call Information: Conference call participation is available via webcast or dial-in. The webcast will be live on Ally’s Investor Relations website in the Events & Presentations section (https://www.ally.com/about/investor/events-presentations/index.html).

To join the conference via dial-in, please pre-register via the following link at least 15 minutes before the call begins: https://register-conf.media-server.com/register/BI8d7b2a06520a45f6ac94fe9a466d5343. Upon registration, you will be provided with the conference dial-in number as well as a unique registrant ID.

A replay of the call will be available via webcast on the Ally Investor Relations website.

About Ally Financial
Ally Financial Inc. (NYSE: ALLY) includes the nation’s largest all-digital bank and auto finance business, driven by a mission to “Do It Right” for its customers and communities. Ally is a U.S. financial holding company with $203 billion in assets and 9.7 million customers (as of September 30, 2026). Ally Bank, Member FDIC, offers online banking products, including high-yield savings and no hidden fee checking, and was the first major U.S. bank to eliminate overdraft fees. Ally also provides investing solutions through Ally Invest, including online brokerage, automated investing, IRAs and personal advice. As a leader in auto finance, Ally provides consumer and dealer financing, insurance, and vehicle remarketing services. Ally’s seasoned corporate finance business provides capital to equity sponsors and middle-market companies. Visit ally.com.

Contacts:

Dan Ignacio
Ally Investor Relations
704-444-5107
dan.ignacio@ally.com

Peter Gilchrist
Ally Communications (Media)
704-644-6299
peter.gilchrist@ally.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ally-financial-reports-third-quarter-2026-financial-results-302913934.html

SOURCE Ally Financial

Continue Reading

Technology

ITURAN LOCATION AND CONTROL LTD. SCHEDULES THIRD QUARTER 2026 RESULTS RELEASE AND CONFERENCE CALL FOR NOVEMBER 24, 2026

Published

on

By

Conference Call Scheduled at 9am Eastern Time

AZOUR, Israel, Oct. 20, 2026 /PRNewswire/ — Ituran Location and Control Ltd. (NASDAQ: ITRN), announced that it will be releasing its third quarter 2026 results on Tuesday, November 24, 2026.

The Company will be hosting a video conference call later that day via Zoom, starting at 9am Eastern Time, 6am Pacific Time and 4pm Israel time. On the call, management will review and present the results and will be available to answer investor questions.

To participate in the Zoom call, please register at the following link:
https://us06web.zoom.us/webinar/register/WN_9R8KjpHlR4GccJZZdrYPEQ  

Following registration, you will be sent the link to the conference call which is accessible either via the Zoom app, or alternatively from a dial-in telephone number. If you have an issue with registration, please contact the Ituran investor relations team, well in advance of the call.

For those unable to participate, the call will be available for replay through the same link, or from a link to the recording on Ituran’s website, beginning within a few hours following the end of the call.

About Ituran

Ituran is a leader in the mobility technology field, providing value-added location-based services, including a full suite of services for the connected car. Ituran offers Stolen Vehicle Recovery, fleet management, as well as mobile asset location, management and control services for vehicles, cargo and personal security for the retail and insurance industries and car manufacturers. Ituran is the largest OEM telematics provider in Latin America. Its products and applications are used by customers in over 20 countries. Ituran is also the founder of the Tel Aviv-based DRIVE startup incubator to promote the development of smart mobility technology.

Ituran’s subscriber base has been growing significantly since the Company’s inception to over 2.7 million subscribers using its location-based services with a market-leading position in Israel and Latin America. Established in 1995, Ituran has approximately 2,800 employees worldwide, with offices in Israel, Brazil, Argentina, Mexico, Ecuador, Colombia, India, Canada and the United States.

For more information, please visit Ituran’s website, at: www.ituran.com

 

 

Company Contact

Udi Mizrahi

Deputy CEO and VP Finance, Ituran

udi_m@ituran.com

(Israel) +972 3 557 1348

International Investor Relations

Ehud Helft

EK Global Investor Relations

ituran@ekgir.com

(US) +1 212 378 8040  

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ituran-location-and-control-ltd-schedules-third-quarter-2026-results-release-and-conference-call-for-november-24-2026-302913839.html

SOURCE Ituran Location and Control Ltd.

Continue Reading

Trending